Ranallo, N.; Roncadori, A.; Gentili, N.; Balzi, W.; Altini, M.; Ghini, V.; Maltoni, R.; Andalò, A.; Cavallucci, M.; Sansovini, M.;
et al. Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study. Biomedicines 2025, 13, 515.
https://doi.org/10.3390/biomedicines13020515
AMA Style
Ranallo N, Roncadori A, Gentili N, Balzi W, Altini M, Ghini V, Maltoni R, Andalò A, Cavallucci M, Sansovini M,
et al. Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study. Biomedicines. 2025; 13(2):515.
https://doi.org/10.3390/biomedicines13020515
Chicago/Turabian Style
Ranallo, Nicoletta, Andrea Roncadori, Nicola Gentili, William Balzi, Mattia Altini, Virginia Ghini, Roberta Maltoni, Alice Andalò, Martina Cavallucci, Maddalena Sansovini,
and et al. 2025. "Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study" Biomedicines 13, no. 2: 515.
https://doi.org/10.3390/biomedicines13020515
APA Style
Ranallo, N., Roncadori, A., Gentili, N., Balzi, W., Altini, M., Ghini, V., Maltoni, R., Andalò, A., Cavallucci, M., Sansovini, M., Fausti, V., Montella, M. T., Massa, I., & Danesi, V.
(2025). Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study. Biomedicines, 13(2), 515.
https://doi.org/10.3390/biomedicines13020515
